My 3 Favorite Growth Stocks to Buy in May

The article highlights three growth stocks as buys: Dutch Bros, e.l.f. Beauty, and MercadoLibre. Dutch Bros is described as trading at a 3.3x forward price-to-sales multiple, with restaurant-level contribution margins around 30% versus about 16% for Starbucks in North America, while e.l.f. Beauty trades at 15.5x forward 2027 earnings and has a major distribution opportunity for Rhode. MercadoLibre is growing revenue 49% in Q1 and is investing to expand its e-commerce and fintech leadership across Latin America.

Analysis

The common thread here is not “cheap growth” so much as operating leverage from distribution density. BROS and ELF are still in the phase where incremental placement matters more than headline revenue growth: once fixed corporate, marketing, and logistics costs are absorbed, margin inflects faster than consensus models assume. That means the market is likely underpricing the slope of earnings revisions over the next 4-8 quarters, especially if same-store sales hold while unit growth stays on plan.

The more interesting second-order effect is competitive pressure on incumbents. BROS expanding with superior unit economics forces legacy beverage chains to spend harder on promotions and speed-of-service, while ELF’s push into premium skincare broadens the shelf-space war in beauty and could squeeze smaller indie brands that lack the same retail muscle. For MELI, the investment cycle is a deliberate land-grab: lower take rates and more shipping subsidies should keep near-term margins noisy, but that is precisely how a platform locks in merchant and consumer behavior before competitors can match the logistics moat.

The main risk is that investors conflate long-duration optionality with immediate multiple support. If consumer demand softens, BROS and ELF could de-rate quickly because their valuation cases rely on sustained top-line compounding rather than current cash flow; MELI has a longer runway but is vulnerable to currency volatility and any sign that logistics spend is not converting into share gains. The key catalyst set over the next 1-2 quarters is not absolute earnings, but whether each company proves that incremental growth is becoming more efficient, not more expensive.

Consensus seems to be focusing on valuation screens and missing regime change: these are not mature retailers, they are distribution platforms in disguise. If management execution stays clean, the market may have to re-rate them not on near-term P/E or P/S, but on the durability of their acquisition economics and the size of the addressable shelf, store, or payment footprint.

Key Decisions for Investors

• Long BROS on weakness for a 6-12 month horizon; best entry is any 8-12% pullback as investors have a habit of overreacting to commodity/consumer headlines. Risk/reward improves if unit growth remains >15% and store-level margins stay near the current range.
• Long ELF as a distribution expansion compounder over the next 12 months. The asymmetric setup is that any retail rollout surprise or SKU expansion drives estimate revisions faster than the market expects; stop-loss on a thesis break if Rhode fails to scale beyond its current channel mix.
• Buy MELI on a 12-18 month horizon as an investment-cycle winner; accept near-term margin compression in exchange for potential multiple expansion if logistics and fintech attach rate continue improving. Prefer staged entries because FX volatility can create sharp drawdowns unrelated to fundamentals.
• Pair long BROS / short SBUX for a 3-6 month relative-value trade. The bet is that unit economics and growth runway matter more than mature brand stability; risk is SBUX uses promotions and menu innovation to slow BROS comp momentum.
• Use call spreads instead of outright longs for ELF or BROS if positioning is crowded. This caps premium paid while preserving upside if the market starts rewarding operating leverage rather than discounting the capex/distribution phase.